NEW
Stock Screener with Intrinsic Value
Alnylam Pharmaceuticals, Inc. (ALNY)
Last Price$238.0(1.1%)
Market Cap$30.1B
1Y Forward Revenue growth
22.5%
1Y Forward EPS growth
(42.6%)
Last EPS & EPS Surprise
($0.87)
18.5% beat
Last 10 Earnings
7 Beat / 3 Miss
ALNY Revenue and EPS Expectations
Crunching data... Almost there!
ALNY Earnings Surprises
Crunching data... Almost there!
ALNY Earnings History
Crunching data... Almost there!
Stock picking tips.
Ultimate guide 2024
Discover the secrets to successful stock picking in 2024!
We asked 1,000 top investors for their insights on the best stocks, investment strategies, and market trends.
FAQ
1. What is Alnylam Pharmaceuticals, Inc. (ALNY) 1-year forward revenue growth estimate?
Alnylam Pharmaceuticals, Inc. (ALNY) 1-year forward revenue growth is estimated at 22.5%.
2. What is Alnylam Pharmaceuticals, Inc. (ALNY) 1-year forward EPS growth estimate?
Alnylam Pharmaceuticals, Inc. (ALNY) 1-year forward EPS growth is estimated at (42.6%).
3. What was Alnylam Pharmaceuticals, Inc. (ALNY) last EPS, and was there a surprise?
Alnylam Pharmaceuticals, Inc. (ALNY) last reported EPS was ($0.87), with a 18.5% beat.
4. What is Alnylam Pharmaceuticals, Inc. (ALNY) performance across the last 10 earnings reports?
Alnylam Pharmaceuticals, Inc. (ALNY) had 7 beats and 3 misses in its last 10 earnings reports.